BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 04, 2011
 |  BC Week In Review  |  Company News  |  Other News

CSL, Abbott, AstraZeneca, Bayer, Bristol-Myers, GlaxoSmithKline, Merck, Pfizer, sanofi-aventis, Takeda pharmaceuticals news

The U.S. Supreme Court ruled unanimously that local health providers participating in the 340B drug discount program do not have a legal right to sue drug manufacturers for alleged drug overpricing. In the court's opinion, Justice Ruth Bader Ginsburg wrote that pricing enforcement is the responsibility of HHS, and that "suits by 340B entities would undermine the agency's efforts to administer both Medicaid and...

Read the full 298 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >